Drug intelligence / Profile preview

Evozac Calming Skin Spray

Development stage: Unknown
Lead developer: Evaux Laboratoires
Modality: Small Molecules, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Hydrogel Systems → Drug Delivery Systems
Administration: Topical

Overview

Evozac Calming Skin Spray is a topical product developed by Evaux Laboratoires, formulated with Évaux thermal spring water. It is designed for the treatment of dermatological toxicities, specifically acne-like eruptions, caused by anti-epidermal growth factor receptor therapy. Clinical trials have shown its efficacy in reducing the number of facial lesions, decreasing the incidence of severe rash, and alleviating associated symptoms when used prophylactically.

Brand names: Evozac Calming Skin Spray

Beyond the preview

Go deeper on Evozac Calming Skin Spray.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Evozac Calming Skin Spray.

Explore the full profile